Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation
Identifieur interne :
002119 ( PascalFrancis/Curation );
précédent :
002118;
suivant :
002120
Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation
Auteurs : Robert E. Burke [
États-Unis]
Source :
-
Movement disorders [ 0885-3185 ] ; 2010.
RBID : Pascal:10-0193328
Descripteurs français
English descriptors
Abstract
Braak and colleagues have proposed a staging scheme for Parkinson's disease (PD) based on patterns of abnormal immunostaining for α-synuclein. They have proposed a temporal sequence in which the appearance of Lewy bodies and neurites in brainstem structures represent the earliest manifestations of the disease, and that this involvement of non-dopaminergic structures long antedates involvement of the substantia nigra and the appearance of the cardinal motor signs that are now required for diagnosis. This proposed scheme has had a wide and profound impact on many aspects of current thinking about PD, and it has already received wide acceptance. Given the importance and growing acceptance of the Braak staging scheme, the Scientific Program Committee for this Educational Symposium to honor the 50th Anniversary of the Parkinson's Disease Foundation agreed that it would be highly worthwhile to devote an entire session of the Scientific Program to consideration of the Braak staging scheme. There was a consensus among members of the Committee that, given the importance of the Braak scheme, it would be of value to create a venue that would stimulate and encourage a thorough and incisive critical analysis.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 25 |
|---|
| A06 | | | | @2 3 @3 SUP1 |
|---|
| A08 | 01 | 1 | ENG | @1 Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation |
|---|
| A09 | 01 | 1 | ENG | @1 Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease |
|---|
| A11 | 01 | 1 | | @1 BURKE (Robert E.) |
|---|
| A12 | 01 | 1 | | @1 FAHN (Stanley) @9 ed. |
|---|
| A12 | 02 | 1 | | @1 MARDER (Karen) @9 ed. |
|---|
| A12 | 03 | 1 | | @1 COTE (Lucien) @9 ed. |
|---|
| A12 | 04 | 1 | | @1 REICH (Stephen G.) @9 ed. |
|---|
| A14 | 01 | | | @1 Departments of Neurology and Pathology, Columbia University, College of Physicians and Surgeons @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A15 | 01 | | | @1 Department of Neurology, Columbia University College of Physicians and Surgeons @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A18 | 01 | 1 | | @1 Parkinson's Disease Foundation @2 New York, NY @3 USA @9 org-cong. |
|---|
| A20 | | | | @2 S76-S77 |
|---|
| A21 | | | | @1 2010 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000189676130120 |
|---|
| A44 | | | | @0 0000 @1 © 2010 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 8 ref. |
|---|
| A47 | 01 | 1 | | @0 10-0193328 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C01 | 01 | | ENG | @0 Braak and colleagues have proposed a staging scheme for Parkinson's disease (PD) based on patterns of abnormal immunostaining for α-synuclein. They have proposed a temporal sequence in which the appearance of Lewy bodies and neurites in brainstem structures represent the earliest manifestations of the disease, and that this involvement of non-dopaminergic structures long antedates involvement of the substantia nigra and the appearance of the cardinal motor signs that are now required for diagnosis. This proposed scheme has had a wide and profound impact on many aspects of current thinking about PD, and it has already received wide acceptance. Given the importance and growing acceptance of the Braak staging scheme, the Scientific Program Committee for this Educational Symposium to honor the 50th Anniversary of the Parkinson's Disease Foundation agreed that it would be highly worthwhile to devote an entire session of the Scientific Program to consideration of the Braak staging scheme. There was a consensus among members of the Committee that, given the importance of the Braak scheme, it would be of value to create a venue that would stimulate and encourage a thorough and incisive critical analysis. |
|---|
| C02 | 01 | X | | @0 002B17 |
|---|
| C02 | 02 | X | | @0 002B17G |
|---|
| C03 | 01 | X | FRE | @0 Maladie de Parkinson @2 NM @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @2 NM @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @2 NM @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Pathologie du système nerveux @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Nervous system diseases @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Sistema nervioso patología @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Evaluation @5 09 |
|---|
| C03 | 03 | X | ENG | @0 Evaluation @5 09 |
|---|
| C03 | 03 | X | SPA | @0 Evaluación @5 09 |
|---|
| C03 | 04 | X | FRE | @0 Corps Lewy @5 10 |
|---|
| C03 | 04 | X | ENG | @0 Lewy body @5 10 |
|---|
| C03 | 04 | X | SPA | @0 Cuerpo Lewy @5 10 |
|---|
| C03 | 05 | X | FRE | @0 Neurite @5 11 |
|---|
| C03 | 05 | X | ENG | @0 Neurite @5 11 |
|---|
| C07 | 01 | X | FRE | @0 Pathologie de l'encéphale @5 37 |
|---|
| C07 | 01 | X | ENG | @0 Cerebral disorder @5 37 |
|---|
| C07 | 01 | X | SPA | @0 Encéfalo patología @5 37 |
|---|
| C07 | 02 | X | FRE | @0 Syndrome extrapyramidal @5 38 |
|---|
| C07 | 02 | X | ENG | @0 Extrapyramidal syndrome @5 38 |
|---|
| C07 | 02 | X | SPA | @0 Extrapiramidal síndrome @5 38 |
|---|
| C07 | 03 | X | FRE | @0 Maladie dégénérative @5 39 |
|---|
| C07 | 03 | X | ENG | @0 Degenerative disease @5 39 |
|---|
| C07 | 03 | X | SPA | @0 Enfermedad degenerativa @5 39 |
|---|
| C07 | 04 | X | FRE | @0 Pathologie du système nerveux central @5 40 |
|---|
| C07 | 04 | X | ENG | @0 Central nervous system disease @5 40 |
|---|
| C07 | 04 | X | SPA | @0 Sistema nervosio central patología @5 40 |
|---|
| N21 | | | | @1 130 |
|---|
| N44 | 01 | | | @1 OTO |
|---|
| N82 | | | | @1 OTO |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Symposium of the Parkinson's Disease Foundation @3 South Street Seaport, Manhattan USA @4 2007-10-11 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C00
Links to Exploration step
Pascal:10-0193328
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation</title>
<author><name sortKey="Burke, Robert E" sort="Burke, Robert E" uniqKey="Burke R" first="Robert E." last="Burke">Robert E. Burke</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology and Pathology, Columbia University, College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0193328</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0193328 INIST</idno>
<idno type="RBID">Pascal:10-0193328</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C00</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002119</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation</title>
<author><name sortKey="Burke, Robert E" sort="Burke, Robert E" uniqKey="Burke R" first="Robert E." last="Burke">Robert E. Burke</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology and Pathology, Columbia University, College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Evaluation</term>
<term>Lewy body</term>
<term>Nervous system diseases</term>
<term>Neurite</term>
<term>Parkinson disease</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Evaluation</term>
<term>Corps Lewy</term>
<term>Neurite</term>
</keywords><front><div type="abstract" xml:lang="en">Braak and colleagues have proposed a staging scheme for Parkinson's disease (PD) based on patterns of abnormal immunostaining for α-synuclein. They have proposed a temporal sequence in which the appearance of Lewy bodies and neurites in brainstem structures represent the earliest manifestations of the disease, and that this involvement of non-dopaminergic structures long antedates involvement of the substantia nigra and the appearance of the cardinal motor signs that are now required for diagnosis. This proposed scheme has had a wide and profound impact on many aspects of current thinking about PD, and it has already received wide acceptance. Given the importance and growing acceptance of the Braak staging scheme, the Scientific Program Committee for this Educational Symposium to honor the 50th Anniversary of the Parkinson's Disease Foundation agreed that it would be highly worthwhile to devote an entire session of the Scientific Program to consideration of the Braak staging scheme. There was a consensus among members of the Committee that, given the importance of the Braak scheme, it would be of value to create a venue that would stimulate and encourage a thorough and incisive critical analysis.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA06><s2>3</s2>
<s3>SUP1</s3>
</fA06><fA08 i1="01" i2="1" l="ENG"><s1>Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease</s1>
</fA09><fA11 i1="01" i2="1"><s1>BURKE (Robert E.)</s1>
</fA11><fA12 i1="01" i2="1"><s1>FAHN (Stanley)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="02" i2="1"><s1>MARDER (Karen)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="03" i2="1"><s1>COTE (Lucien)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="04" i2="1"><s1>REICH (Stephen G.)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>Departments of Neurology and Pathology, Columbia University, College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA15 i1="01"><s1>Department of Neurology, Columbia University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15><fA18 i1="01" i2="1"><s1>Parkinson's Disease Foundation</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<s9>org-cong.</s9>
</fA18><fA20><s2>S76-S77</s2>
</fA20><fA21><s1>2010</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000189676130120</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>8 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>10-0193328</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC01 i1="01" l="ENG"><s0>Braak and colleagues have proposed a staging scheme for Parkinson's disease (PD) based on patterns of abnormal immunostaining for α-synuclein. They have proposed a temporal sequence in which the appearance of Lewy bodies and neurites in brainstem structures represent the earliest manifestations of the disease, and that this involvement of non-dopaminergic structures long antedates involvement of the substantia nigra and the appearance of the cardinal motor signs that are now required for diagnosis. This proposed scheme has had a wide and profound impact on many aspects of current thinking about PD, and it has already received wide acceptance. Given the importance and growing acceptance of the Braak staging scheme, the Scientific Program Committee for this Educational Symposium to honor the 50th Anniversary of the Parkinson's Disease Foundation agreed that it would be highly worthwhile to devote an entire session of the Scientific Program to consideration of the Braak staging scheme. There was a consensus among members of the Committee that, given the importance of the Braak scheme, it would be of value to create a venue that would stimulate and encourage a thorough and incisive critical analysis.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02><fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Evaluation</s0>
<s5>09</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Evaluation</s0>
<s5>09</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Evaluación</s0>
<s5>09</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Corps Lewy</s0>
<s5>10</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Lewy body</s0>
<s5>10</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Cuerpo Lewy</s0>
<s5>10</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Neurite</s0>
<s5>11</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Neurite</s0>
<s5>11</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07><fN21><s1>130</s1>
</fN21><fN44 i1="01"><s1>OTO</s1>
</fN44><fN82><s1>OTO</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Symposium of the Parkinson's Disease Foundation</s1>
<s3>South Street Seaport, Manhattan USA</s3>
<s4>2007-10-11</s4>
</fA30>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002119 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002119 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:10-0193328
|texte= Evaluation of the Braak Staging Scheme for Parkinson's disease: Introduction to a Panel Presentation
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
